MK-677's Unfinished Story: Mapping the Evidence Gaps, Ongoing Trials, and the Research Road Ahead
Despite decades of preliminary investigation, MK-677 remains a compound with significant unanswered questions surrounding its long-term safety profile and extended physiological effects. This investigative piece surveys the current clinical trial landscape, identifies the health outcomes that still lack robust longitudinal data, and examines the structural reasons why ibutamoren continues to occupy research — rather than approved therapeutic — status. It is a candid assessment of what science cu